CDKN2A hyper-methylation has been suggested as a predictive factor for unfavorable prognosis of, e.g., colorectal cancer72, 73, rectal cancer74, and adult acute lymphoblastic leukemia patients harboring BCR-ABL1 fusions75. Here, CDKN2A is linked to acute lymphoblastic leukemia.